SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001104659-22-050362
Filing Date
2022-04-26
Accepted
2022-04-26 16:25:51
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM F-3 tm2213007-1_f3.htm F-3 789495
2 EXHIBIT 5.1 tm2213007d2_ex5-1.htm EX-5.1 29651
3 EXHIBIT 5.2 tm2213007d2_ex5-2.htm EX-5.2 16038
4 EXHIBIT 8.2 tm2213007d2_ex8-2.htm EX-8.2 19336
5 EXHIBIT 23.1 tm2213007d2_ex23-1.htm EX-23.1 2110
6 EX-FILING FEES tm2213007d2_ex-filingfees.htm EX-FILING FEES 37215
7 GRAPHIC lg_adagene-4clr.jpg GRAPHIC 12592
8 GRAPHIC tm2213007d1-fc_corpobw.jpg GRAPHIC 89307
9 GRAPHIC tm2213007d1-pc_neobody4c.jpg GRAPHIC 320003
10 GRAPHIC tm2213007d1-tbl_program4c.jpg GRAPHIC 105986
11 GRAPHIC tm2213007d2_ex5-2img001.jpg GRAPHIC 2174
12 GRAPHIC tm2213007d2_ex5-2img002.jpg GRAPHIC 2182
13 GRAPHIC tm2213007d2_ex8-2img01.jpg GRAPHIC 4258
  Complete submission text file 0001104659-22-050362.txt   1633954
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-264486 | Film No.: 22854706
SIC: 2834 Pharmaceutical Preparations